- Home
- PBYI vs CLPT Comparison
PBYI vs CLPT Comparison
Compare PBYI & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | CLPT |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | 179 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 403.6M | 435.7M |
| IPO Year | 2011 | 2009 |
Fundamental Metrics
Financial Performance| Metric | PBYI | CLPT |
|---|---|---|
| Price | $7.93 | $14.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 323.2K | ★ 469.9K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $27,685,000.00 | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $3.04 | $8.27 |
| 52 Week High | $8.75 | $30.10 |
Technical Indicators
Market Signals| Indicator | PBYI | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 45.30 | 42.53 |
| Support Level | $7.64 | $13.38 |
| Resistance Level | $7.83 | $15.09 |
| Average True Range (ATR) | 0.37 | 0.75 |
| MACD | -0.08 | -0.23 |
| Stochastic Oscillator | 13.16 | 22.47 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.